A Multicenter Randomized Controlled Trial of Neoadjuvant Adebrelimab Combined With Chemotherapy for Resectable Small Cell Lung Cancer (SCLC)
Latest Information Update: 16 Jul 2024
At a glance
- Drugs Adebrelimab (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Jul 2024 New trial record